Shane McCarthy
Regeneron (United States)(US)Progenics Pharmaceuticals (United States)(US)
Publications by Year
Research Areas
Genomic variations and chromosomal abnormalities, Genetic Associations and Epidemiology, Genomics and Rare Diseases, Congenital heart defects research, SARS-CoV-2 and COVID-19 Research
Most-Cited Works
- → Rare Structural Variants Disrupt Multiple Genes in Neurodevelopmental Pathways in Schizophrenia(2008)1,822 cited
- → Modelling schizophrenia using human induced pluripotent stem cells(2011)1,403 cited
- → Biobank-driven genomic discovery yields new insight into atrial fibrillation biology(2018)913 cited
- → A Protein-Truncating HSD17B13 Variant and Protection from Chronic Liver Disease(2018)778 cited
- → Microduplications of 16p11.2 are associated with schizophrenia(2009)732 cited
- → A recurrent 16p12.1 microdeletion supports a two-hit model for severe developmental delay(2010)671 cited
- → Duplications of the neuropeptide receptor gene VIPR2 confer significant risk for schizophrenia(2011)